Introduction
Diabetic foot ulcers (DFUs) represent a severe complication of diabetes, often leading to chronic infections and, in many cases, lower-limb amputations. The underlying pathology involves impaired vascularization and a persistent inflammatory environment that hinders natural healing. While tissue engineering has introduced various scaffolds and stem cell therapies, two primary obstacles remain: achieving a sufficiently high density of therapeutic cells within the wound and preventing the rapid washout of essential growth factors like basic fibroblast growth factor (bFGF).
This research introduces a novel bioengineering strategy: a "book-shaped" decellularized dermal matrix (BDDM) designed to maximize cell loading and a molecularly tethered growth factor system to ensure sustained therapeutic delivery.
Engineering the "Book-Shaped" Scaffold
To overcome the limitations of traditional scaffolds, researchers developed a book-shaped decellularized dermal matrix (BDDM). Human skin was decellularized to create a biocompatible, low-immunogenic matrix that retains the histology and microstructure of native tissue.
The matrix was then sliced into a unique "book" geometry, featuring three 300 µm-thick "pages." This design significantly increases the surface area for cell attachment without expanding the graft's overall footprint. This multi-layered structure addresses the "diffusion limit" by providing channels for nutrient and oxygen transport between the interleaved layers.
ASC Cell Sheets and the "Sandwich" Assembly
Rather than using traditional cell suspensions, which can lose their natural extracellular matrix (ECM) during detachment, the team utilized Adipose-Derived Stromal Cells (ASCs) grown into intact "sheets." These sheets preserve vital cell-to-cell junctions and their own microenvironment, enhancing survival upon transplantation.
These ASC sheets were interleaved between the pages of the BDDM. To further enhance the scaffold's regenerative potential, a recombinant growth factor (CBD-bFGF) was synthesized. By fusing bFGF with a Collagen-Binding Domain (CBD), the researchers enabled the growth factor to physically tether itself to the collagen fibers of the BDDM, preventing rapid washout and ensuring a sustained release profile over 14 days.
Key Findings
Enhanced Angiogenesis and Healing
In a diabetic rat model, the ASCs/CBD-bFGF/BDDM "sandwich" graft demonstrated superior performance compared to standard decellularized dermal matrices. Key results included:
- Superior Vascularization: By day 7, the treatment group showed significantly higher densities of both total (CD31+) and mature (αSMA+) blood vessels, indicating robust angiogenesis.
- Accelerated Wound Closure: By day 21, wounds treated with the functionalized sandwich graft were nearly closed, exhibiting organized collagen deposition and effective re-epithelialization.
- Biocompatibility: The scaffold maintained low immunogenicity, effectively avoiding a pro-inflammatory response in macrophage cultures.
Conclusion
The integration of a book-shaped geometry with molecularly tethered growth factors and intact cell sheets provides a powerful platform for diabetic wound care. By maximizing cell density and ensuring the sustained presence of regenerative signals, this approach offers a promising path forward for treating chronic, non-healing wounds.
Summary updated